Research and Markets: Epilepsy Market in the US 2015-2019 - Expected to Grow 4.85% By 2019

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/7v54zd/epilepsy_market) has announced the addition of the "Epilepsy Market in the US 2015-2019" report to their offering.

The analysts forecast the Epilepsy market in the US to grow at a CAGR of 4.85 percent over the period 2014-2019.

The Epilepsy market in the US can be divided into three segments:

  1. First-generation Drugs
  2. Second-generation Drugs
  3. Third-generation Drugs.

This report covers the present scenario and the growth prospects of the Epilepsy market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated through the sales of anti-epileptic drugs approved in the US to treat the symptoms of epilepsy.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the Epilepsy Market in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Questions Answered in this Report:

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key Market Trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Companies Profiled:

  • GlaxoSmithKline
  • Pfizer
  • UCB

Report Structure:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Disease Overview

06. Introduction

07. Market Landscape

08. Market Segmentation by Generation of Drugs

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

17. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/7v54zd/epilepsy_market

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices